Try 12 Weeks of Pharmacogenomics Reporter for only $95!*
In today’s competitive research environment, success depends on having the most up-to-date information. Scientists and business leaders working with pharmacogenomics rely on PGx Reporter to bring them exclusive, in-depth business, technology, and regulatory news on:
Pharmacogenomics
FDA regulation & relabeling
Reimbursement
Clinical trials
Molecular diagnostics and theranostics
In addition, every online subscription to PGx Reporter provides this important coverage:
Technology transfer and translational research
Funding reports, including research grants and venture capital
Exclusive interviews with business, technology, regulatory, and research leaders
New product launches and upgrades
Summaries of relevant research papers
Management news: hirings, firings, and promotions
Every subscriber receives a weekly email bulletin containing clickable links to the latest headlines plus unlimited full-text access to the entire online archive of Pharmacogenomics Reporter.
*12-week introductory offer for new subscribers only. Customers who have previously ordered an introductory subscription within the past 12 months will be invoiced the difference of the full-year rate of $985.